The Claim
Patients with stable ischemic heart disease who are taking statins and achieve LDL-C levels between 70 and 100 mg/dL have a lower risk of major adverse cardiac events compared to those with LDL-C levels between 100 and 130 mg/dL.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
People with heart disease who take statin drugs and get their bad cholesterol down to a lower range (70-100) are less likely to have serious heart problems than those with slightly higher cholesterol (100-130).
See the scientific wording
Patients with stable ischemic heart disease taking statins who achieve LDL-C levels between 70 and 100 mg/dL have a lower risk of major adverse cardiac events compared to those with LDL-C levels between 100 and 130 mg/dL, as shown by an adjusted hazard ratio of 0.89 (95% CI, 0.84-0.94; P < .001) in a cohort of 31,619 adherent patients.
What the research says
1 studyThe study found that patients with heart disease on statins who had LDL cholesterol between 70 and 100 had fewer heart problems than those with levels between 100 and 130, which matches the claim.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.